These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 9511060

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
    Nakashio S, Iwasawa H, Iino S, Shimada J.
    Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
    [Abstract] [Full Text] [Related]

  • 23. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V, Bozdogan B, Leclercq R, Garry L, Feger C, Carbon C, Fantin B.
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [Abstract] [Full Text] [Related]

  • 24. Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.
    Sader HS, Jones RN, Ballow CH, Biedenbach DJ, Cered RF, GSMART Latin America Study Group.
    Braz J Infect Dis; 2001 Feb; 5(1):21-31. PubMed ID: 11290311
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.
    Bozdogan B, Leclercq R.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2720-5. PubMed ID: 10543753
    [Abstract] [Full Text] [Related]

  • 27. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P, Lemaire S, Denis O, Tulkens PM, Van Bambeke F, Glupczynski Y.
    J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
    [Abstract] [Full Text] [Related]

  • 28. In-vitro bactericidal activity of quinupristin/dalfopristin against adherent Staphylococcus aureus.
    Berthaud N, Desnottes JF.
    J Antimicrob Chemother; 1997 May; 39 Suppl A():99-102. PubMed ID: 9511072
    [Abstract] [Full Text] [Related]

  • 29. Antistaphylococcal activities of quinupristin/dalfopristin in vitro across platelet-fibrin matrices and in experimental endocarditis.
    Berthaud N, Huet Y, Diallo N, Desnottes JF.
    J Antimicrob Chemother; 1997 May; 39 Suppl A():93-8. PubMed ID: 9511071
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
    Hamel A, Caillon J, Jacqueline C, Batard E, Potel G.
    Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
    [Abstract] [Full Text] [Related]

  • 31. Interactions of quinupristin-dalfopristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalfopristin alone was not bactericidal.
    Fuchs PC, Barry AL, Brown SD.
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2662-5. PubMed ID: 11502549
    [Abstract] [Full Text] [Related]

  • 32. Antimicrobial characteristics of quinupristin/dalfopristin (Synercid at 30:70 ratio) compared to alternative ratios for in vitro testing.
    Jamjian C, Barrett MS, Jones RN.
    Diagn Microbiol Infect Dis; 1997 Apr; 27(4):129-38. PubMed ID: 9154409
    [Abstract] [Full Text] [Related]

  • 33. In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea.
    Hwang SH, Kim MN, Pai CH, Huh DH, Shin WS.
    Yonsei Med J; 2000 Oct; 41(5):563-9. PubMed ID: 11079615
    [Abstract] [Full Text] [Related]

  • 34. Combining quinupristin/dalfopristin with other agents for resistant infections.
    Brown J, Freeman BB.
    Ann Pharmacother; 2004 Apr; 38(4):677-85. PubMed ID: 14990776
    [Abstract] [Full Text] [Related]

  • 35. In vitro activity of quinupristin/dalfopristin and newer quinolones combined with gentamicin against resistant isolates of Enterococcus faecalis and Enterococcus faecium.
    Giamarellos-Bourboulis EJ, Sambatakou H, Grecka P, Giamarellou H.
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):657-61. PubMed ID: 9832270
    [Abstract] [Full Text] [Related]

  • 36. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
    Tünger A, Aydemir S, Uluer S, Cilli F.
    Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
    [Abstract] [Full Text] [Related]

  • 37. Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics.
    Pavie J, Lefort A, Zarrouk V, Chau F, Garry L, Leclercq R, Fantin B.
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3061-4. PubMed ID: 12183272
    [Abstract] [Full Text] [Related]

  • 38. Antimicrobial activity of quinupristin/dalfopristin, a new injectable streptogramin with a wide Gram-positive spectrum.
    Speciale A, La Ferla K, Caccamo F, Nicoletti G.
    Int J Antimicrob Agents; 1999 Sep; 13(1):21-8. PubMed ID: 10563401
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan.
    Luh KT, Hsueh PR, Teng LJ, Pan HJ, Chen YC, Lu JJ, Wu JJ, Ho SW.
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3374-80. PubMed ID: 11083643
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.